Dr. BB
ActiveSummary
The computed 12-month bankruptcy probability of Dr. BB is 1.5% (moderate). The 2025 annual accounts show equity of €3,607 and a net result of €1,940. The company has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals.
Overview
- Equity
- €3,607
- Profit
- €1,940
Why 63raises riskFounded in 2024No main activity registeredlowers riskSize: total assets €31,330Liquidity: current ratio 1.04, cash €12,176Show the evidence
Checked score
About 2 in 100 comparable companies go bankrupt within 12 months (an estimate).
How it is calculated
The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (no NACE code, micro): better than 23% on solvency, 32% on liquidity and 59% on profitability.
The bankruptcy probability was computed on 21-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).
Credit check for your own amount and term
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
Searched, nothing found (1)
- Annual accounts filedfinancial year 2025 · micro…
- IncorporationAppointment: BAUTERS Emma (director) ·…
Financials · financial year 2025, micro format
Turnover and EBIT margin not published: the micro format does not require them.
Peer companies
Historical observationOf the 2,390 companies that looked in July 2024 the way this one looks now, 1.2% went bankrupt within 24 months and 96.7% are still going.
- Micro
- under 2 years old
- solvency 10 to 30%
- a profit of 5% of the balance sheet or more
A further 0.2% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a higher bankruptcy probability: 1.5% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,473 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 1.0% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 2,390 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
| Line | 2025 |
|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €975 |
| Other operating charges640/8 | €456 |
| Gross operating margin9900 | €5,566 |
| Operating profit (loss)9901 | €4,135 |
| Financial charges65/66B | €64 |
| Recurring financial charges65 | €64 |
| Profit (loss) for the period before taxes9903 | €4,071 |
| Income taxes67/77 | €2,131 |
| Profit (loss) for the period9904 | €1,940 |
| Profit (loss) for the period to be appropriated9905 | €1,940 |
| Line | 2025 | |
|---|---|---|
| Assets | ||
| Total assets20/58 | €31,330 | |
| Fixed assets21/28 | €2,619 | |
| Tangible fixed assets22/27 | €2,619 | |
| Furniture and vehicles24 | €2,619 | |
| Current assets29/58 | €28,711 | |
| Cash at bank and in hand54/58 | €12,176 | |
| Deferred charges and accrued income490/1 | €16,535 | |
| Equity and liabilities | ||
| Total equity and liabilities10/49 | €31,330 | |
| Equity10/15 | €3,607 | |
| Contributions10/11 | €2,500 | |
| Reserves13 | €1,107 | |
| Distributable reserves133 | €1,107 | |
| Profit (loss) carried forward14 | €0 | |
| Amounts payable17/49 | €27,723 | |
| Amounts payable within one year42/48 | €27,723 | |
| Trade debts44 | €6,156 | |
| Suppliers440/4 | €6,156 | |
| Taxes, remuneration and social security45 | €3,631 | |
| Taxes450/3 | €3,631 | |
| Other amounts payable47/48 | €17,936 | |
| Line | 2025 |
|---|---|
| Profit (loss) for the period9904 | €1,940 |
| + Depreciation and write-downs630 | €975 |
| Operating cash flow (approximation) | €2,915 |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Filings with the National Bank (1)
| Financial year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2025 | micro format | 15-07-2026 | 2026-00301557 |
Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.
Directors
Mandate history
- Board
| Name | Functions and periods |
|---|---|
| BAUTERS Emma |
|
Owners and capital
Capital and shareholders
- BAUTERS Emma Gilbert Rita 100 shares (100%) · €2,500
The Belgian Official Gazette names shareholders only when an act mentions them; the share register itself is not published.
- 25-10-2024 Incorporation · €2,500 · 100 shares
Group and network
Connections & network
1 current directorThe network starts from this company’s directors. Other companies they run appear here as nodes.
History
Acts, filings and financial milestones
25-10
Gazette deed
IncorporationAppointment: BAUTERS Emma (director) · Founder · Founding capital9 facts ▸
- Founder, BAUTERS Emma Gilbert Rita
- Founding capital, €2,500
- General meeting, “overeenkomstig wet, comparanten” (deed in Dutch)
- Registered office clause, “8980 Zonnebeke (Zandvoorde), Kortestraat 3” (deed in Dutch)
- Other provision, “website en e-mailadres” (deed in Dutch)
- Board rule, 1
- Director appointment, BAUTERS Emma (director (not named in the articles))
- Pre-incorporation commitments, Dr. BB
- Incorporation, “Dr. BB” (deed in Dutch)
Register details
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 21 October 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.
Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.
Sites & property
1 establishment unit
1 parcel
| Cadastral parcel | Region | Area | Buildings | Height / floors |
|---|---|---|---|---|
| 33035A0709/00F000 | Flanders | 786 m² | 1 · 83 m² | 7.0 m · 2 |
How the parcels are linked
Articles of association
What the company does
- PurposeThe activities the company may carry out under its articles.
- “Het uitoefenen van de geneeskunde door de arts-aandeelhouder op het gebied van de gynaecologie-verloskunde, met bijzondere expertise in…” (deed in Dutch)
Text of the purpose (deed in Dutch)
“Het uitoefenen van de geneeskunde door de arts-aandeelhouder op het gebied van de gynaecologie-verloskunde, met bijzondere expertise in bekkenbodempathologie, dit rekening houdend met de Code van Medische Deontologie.”
- DurationHow long the company exists; usually unlimited, so until it is dissolved.
- Unlimited
- Name clauseThe name the company operates under according to its articles.
- Dr. BB
- Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
- “Vlaams Gewest” (deed in Dutch)
Who represents it, and how
- Board ruleHow the board is made up, meets and takes decisions.
- “Geheel van bevoegdheden met mogelijkheid deel te delegeren, duur van de medische activiteiten” (deed in Dutch)“Vaste of evenredige vergoeding, algemene kosten los van representatie-,reis-en verplaatsingskosten” (deed in Dutch)1 more provision on this in the deed
Capital, shares and profit
- Kind of sharesWhich classes of shares exist and what rights each class carries.
- “100, gelijk recht in de winstverdeling en in het vereffeningsaldo” (deed in Dutch)
Meetings and financial year
- Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
- Last Saturday of June at 11:00
Oversight and winding up
- Statutory auditorA statutory auditor is a registered auditor who checks the accounts; small companies need not have one. According to the deed, the legal criteria do not require one here.
- No statutory auditor
- Dissolution ruleWhen and by whom the company can be dissolved.
- “In vormen vereist voor statutenwijziging, algemene vergadering” (deed in Dutch)
- Liquidation ruleHow assets are shared after dissolution: creditors first, then shareholders.
- “Om welke reden en op welk ogenblik ook, onverminderd recht van algemene vergadering om één of meerdere vereffenaars aan te duiden, hun…” (deed in Dutch)